Emerging role of AMP-activated protein kinase in endocrine control of metabolism in the liver

Molecular and Cellular Endocrinology

Volumn 366, Issue 2, 2013, Pages 152-162

  Hasenour, Clinton M ^a   Berglund, Eric D ^a,b   Wasserman, David H ^a  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

Adiponectin; AMPK; Endocrine; Energy charge; Glucagon; Metabolism

Indexed keywords

ADENOSINE PHOSPHATE; ADENOSINE TRIPHOSPHATE; ADIPONECTIN; FATTY ACID; GHRELIN; GLUCAGON; GLUCOSE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE ALPHA 1; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE ALPHA 1 ALPHA 2; INSULIN; LEPTIN; MAMMALIAN TARGET OF RAPAMYCIN COMPLEX 1; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA COACTIVATOR 1ALPHA; PROTEIN CRTC2; PROTEIN SERINE THREONINE KINASE; RESISTIN; STEROL REGULATORY ELEMENT BINDING PROTEIN 1C; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

ENDOCRINE FUNCTION; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; FATTY ACID TRANSPORT; GLUCONEOGENESIS; HORMONAL REGULATION; HORMONE RELEASE; HUMAN; LIPID OXIDATION; LIPOGENESIS; LIPOLYSIS; LIVER METABOLISM; METABOLIC REGULATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN SYNTHESIS INHIBITION; REVIEW; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION;

ADIPONECTIN; AMP-ACTIVATED PROTEIN KINASES; ANIMALS; ENDOCRINE SYSTEM; ENERGY METABOLISM; GENE EXPRESSION REGULATION; GHRELIN; GLUCAGON; GLUCOSE; HUMANS; INSULIN; LEPTIN; LIVER; MICE; RESISTIN; SIGNAL TRANSDUCTION;

EID: 84872666094     PISSN: 03037207     EISSN: 18728057     Source Type: Journal    
DOI: 10.1016/j.mce.2012.06.018     Document Type: Review

References (129)

1. Altarejos J.Y., Montminy M. CREB and the CRTC coactivators: sensors for hormonal and metabolic signals. Nat. Rev. Mol. Cell. Biol. 2011, 12:141-151.
2. Anderson K.A., Means R.L., Huang Q.H., Kemp B.E., Goldstein E.G., Selbert M.A., Edelman A.M., Fremeau R.T., Means A.R. Components of a calmodulin-dependent protein kinase cascade. Molecular cloning, functional characterization and cellular localization of Ca2+/calmodulin-dependent protein kinase kinase beta. J. Biol. Chem. 1998, 273:31880-31889.
3. Andreelli F., Foretz M., Knauf C., Cani P.D., Perrin C., Iglesias M.A., Pillot B., Bado A., Tronche F., Mithieux G., Vaulont S., Burcelin R., Viollet B. Liver adenosine monophosphate-activated protein kinase-alpha2 catalytic subunit is a key target for the control of hepatic glucose production by adiponectin and leptin but not insulin. Endocrinology 2006, 147:2432-2441.
4. Awazawa M., Ueki K., Inabe K., Yamauchi T., Kaneko K., Okazaki Y., Bardeesy N., Ohnishi S., Nagai R., Kadowaki T. Adiponectin suppresses hepatic SREBP1c expression in an AdipoR1/LKB1/AMPK dependent pathway. Biochem. Biophys. Res. Commun. 2009, 382:51-56.
5. Banerjee R.R., Rangwala S.M., Shapiro J.S., Rich A.S., Rhoades B., Qi Y., Wang J., Rajala M.W., Pocai A., Scherer P.E., Steppan C.M., Ahima R.S., Obici S., Rossetti L., Lazar M.A. Regulation of fasted blood glucose by resistin. Science 2004, 303:1195-1198.
6. Barazzoni R., Bosutti A., Stebel M., Cattin M.R., Roder E., Visintin L., Cattin L., Biolo G., Zanetti M., Guarnieri G. Ghrelin regulates mitochondrial-lipid metabolism gene expression and tissue fat distribution in liver and skeletal muscle. Am. J. Physiol. Endocrinol. Metab. 2005, 288:E228-E235.
7. Baum J.I., Kimball S.R., Jefferson L.S. Glucagon acts in a dominant manner to repress insulin-induced mammalian target of rapamycin complex 1 signaling in perfused rat liver. Am. J. Physiol. Endocrinol. Metab. 2009, 297:E410-E415.
8. Beg Z.H., Allmann D.W., Gibson D.M. Modulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase activity with cAMP and with protein fractions of rat liver cytosol. Biochem. Biophys. Res. Commun. 1973, 54:1362-1369.
9. Berg A.H., Combs T.P., Du X., Brownlee M., Scherer P.E. The adipocyte-secreted protein Acrp30 enhances hepatic insulin action. Nat. Med. 2001, 7:947-953.
10. Berglund E.D., Kang L., Lee-Young R.S., Hasenour C.M., Lustig D.G., Lynes S.E., Donahue E.P., Swift L.L., Charron M.J., Wasserman D.H. Glucagon and lipid interactions in the regulation of hepatic AMPK signaling and expression of PPARalpha and FGF21 transcripts in vivo. Am. J. Physiol. Endocrinol. Metab. 2010, 299:E607-E614.
11. Berglund E.D., Lee-Young R.S., Lustig D.G., Lynes S.E., Donahue E.P., Camacho R.C., Meredith M.E., Magnuson M.A., Charron M.J., Wasserman D.H. Hepatic energy state is regulated by glucagon receptor signaling in mice. J. Clin. Invest. 2009, 119:2412-2422.
12. Berglund E.D., Lustig D.G., Baheza R.A., Hasenour C.M., Lee-Young R.S., Donahue E.P., Lynes S.E., Swift L.L., Charron M.J., Damon B.M., Wasserman D.H. Hepatic glucagon action is essential for exercise-induced reversal of mouse fatty liver. Diabetes 2011, 60:2720-2729.
13. Biggs W.H., Meisenhelder J., Hunter T., Cavenee W.K., Arden K.C. Protein kinase B/Akt-mediated phosphorylation promotes nuclear exclusion of the winged helix transcription factor FKHR1. Proc. Natl. Acad. Sci. USA 1999, 96:7421-7426.
14. Brown M.S., Goldstein J.L. Selective versus total insulin resistance. a pathogenic paradox. Cell Metab. 2008, 7:95-96.
15. Brownsey R.W., Boone A.N., Elliot J.E., Kulpa J.E., Lee W.M. Regulation of acetyl-CoA carboxylase. Biochem. Soc. Trans. 2006, 34:223-227.
16. Burgess S.C., He T., Yan Z., Lindner J., Sherry A.D., Malloy C.R., Browning J.D., Magnuson M.A. Cytosolic phosphoenolpyruvate carboxykinase does not solely control the rate of hepatic gluconeogenesis in intact mouse liver. Cell Metab. 2007, 5:313-320.
17. Burgess S.C., Leone T.C., Wende A.R., Croce M.A., Chen Z., Sherry A.D., Malloy C.R., Finck B.N. Diminished hepatic gluconeogenesis via defects in tricarboxylic acid cycle flux in peroxisome proliferator-activated receptor γ coactivator-1α (PGC-1α)-deficient mice. J. Biol. Chem. 2006, 281:19000-19008.
18. Camacho R.C., Donahue E.P., James F.D., Berglund E.D., Wasserman D.H. Energy state of the liver during short-term and exhaustive exercise in C57BL/6J mice. Am. J. Physiol. Endocrinol. Metab. 2006, 290:E405-E408.
19. Cantó C., Gerhart-Hines Z., Feige J.N., Lagouge M., Noriega L., Milne J.C., Elliot P.J., Puigserver P., Auwerx J. AMPK regulates energy expenditure by modulating NAD+ metabolism and SIRT1 activity. Nature. 2009, 458:1056-1060.
20. Cantó C., Jiang L.Q., Deshmukh A.S., Mataki C., Coste A., Lagouge M., Zierath J.R., Auwerx J. Interdependence of AMPK and SIRT1 for metabolic adaptation to fasting and exercise in skeletal muscle. Cell Metab. 2010, 11:213-219.
21. Carling D., Zammit V.A., Hardie D.G. A common bicyclic protein kinase cascade inactivates the regulatory enzymes of fatty acid and cholesterol biosynthesis. FEBS Lett. 1987, 223:217-222.
22. Carlson C.L., Winder W.W. Liver AMP-activated protein kinase and acetyl-CoA carboxylase during and after exercise. J. Appl. Physiol. 1999, 86:669-674.
23. 2+ in hepatocytes following alpha 1-adrenergic stimulation. Studies on Quin-2-loaded hepatocytes. J. Biol. Chem. 1983, 258:8769-8773.
24. Chau M.D., Gao J., Yang Q., Wu Z., Gromada J. Fibroblast growth factor 21 regulates energy metabolism by activating the AMPK-SIRT1-PGC1alpha pathway. Proc. Natl. Acad. Sci. USA 2010, 107:12553-12558.
25. Combs T.P., Berg A.H., Obici S., Scherer P.E., Rossetti L. Endogenous glucose production is inhibited by the adipose-derived protein Acrp30. J. Clin. Invest. 2001, 108:1875-1881.
26. Dentin R., Liu Y., Koo S.H., Hedrick S., Vargas T., Heredia J., Yates J., Montminy M. Insulin modulates gluconeogenesis by inhibition of the coactivator TORC2. Nature 2007, 449:366-369.
27. Dubbelhuis P.H., Meijer A.J. Hepatic amino acid-dependent signaling is under the control of AMP-dependent protein kinase. FEBS. Lett. 2002, 521:39-42.
28. Dzamko N., van Denderen B.J., Hevener A.L., Jørgensen S.B., Honeyman J., Galic S., Chen Z.P., Watt M.J., Campbell D.J., Steinberg G.R., Kemp B.E. AMPK beta1 deletion reduces appetite, preventing obesity and hepatic insulin resistance. J. Biol. Chem. 2010, 285:115-122.
29. Exton J.H., Park C.R. The stimulation of gluconeogenesis from lactate by epinephrine, glucagon, cyclic 3',5'-adenylate in the perfused rat liver. Pharmacol. Rev. 1966, 18:181-188.
30. Feige J.N., Lagouge M., Cantó C., Strehle A., Houten S.M., Milne J.C., Lambert P.D., Mataki C., Elliot P.J., Auwerx J. Specific SIRT1 activation mimics low energy levels and protects against diet-induced metabolic disorders by enhancing fat oxidation. Cell Metab. 2008, 8:347-358.
31. Foretz M., Ancellin N., Andreelli F., Saintillan Y., Grondin P., Kahn A., Thorens B., Vaulont S., Viollet B. Short-term overexpression of a constitutively active form of AMP-activated protein kinase in the liver leads to mild hypoglycemia and fatty liver. Diabetes 2005, 54:1331-1339.
32. Foretz M., Hébrard S., Leclerc J., Zarrinpashneh E., Soty M., Mithieux G., Sakamoto K., Andreelli F., Viollet B. Metformin inhibits hepatic gluconeogenesis in mice independently of the LKB1/AMPK pathway via a decrease in hepatic energy state. J. Clin. Invest. 2010, 120:2355-2369.
33. Foretz M., Pacot C., Dugail I., Lemarchand P., Guichard C., Le Liépvre X., Berthelier-Lubrano C., Spiegelman B., Kim J.B., Ferré P., Foufelle F. ADD1/SREBP-1c is required in the activation of hepatic lipogenic gene expression by glucose. Mol. Cell. Biol. 1999, 19:3760-3768.
34. Gerhart-Hines Z., Rodgers J.T., Bare O., Lerin C., Kim S.H., Mostoslavsky R., Alt F.W., Wu Z., Puigserver P. Metabolic control of muscle mitochondrial function and fatty acid oxidation through SIRT1/PGC-1alpha. EMBO J. 2007, 26:1913-1923.
35. Gonzalez G.A., Montminy M.R. Cyclic AMP stimulates somatostatin gene transcription by phosphorylation of CREB at serine 133. Cell 1989, 59:675-680.
36. Granner D., Andreone T., Sasaki K., Beale E. Inhibition of transcription of the phosphoenolpyruvate carboxykinase gene by insulin. Nature 1983, 305:549-551.
37. Guigas B., Taleux N., Foretz M., Detaille D., Andreelli F., Viollet B., Hue L. AMP-activated protein kinase-independent inhibition of hepatic mitochondrial oxidative phosphorylation by AICA riboside. Biochem. J. 2007, 404:499-507.
38. Gwinn D.M., Shackelford D.B., Egan D.F., Mihaylova M.M., Mery A., Vasquez D.S., Turk B.E., Shaw R.J. AMPK phosphorylation of raptor mediates a metabolic checkpoint. Mol. Cell. 2008, 30:214-226.
39. Halseth A.E., Rhéaume N., Messina A.B., Reed E.K., Krishna M.G., Flakoll P.J., Lacy D.B., Wasserman D.H. Regulation of hepatic glutamine metabolism during exercise in the dog. Am. J. Physiol. 1998, 275:E655-E664.
40. Handschin C., Lin J., Rhee J., Pever A.K., Chin S., Wu P.H., Meyer U.A., Spiegelman B.M. Nutritional regulation of hepatic heme biosynthesis and porphyria through PGC-1alpha. Cell 2005, 122:505-515.
41. Hardie D.G., Hawley S.A. AMP-activated protein kinase: the energy charge hypothesis revisited. Bioessays 2001, 23:1112-1119.
42. Hawley S.A., Boudeau J., Reid J.L., Mustard K.J., Udd L., Mäkelä T.P., Alessi D.R., Hardie D.G. Complexes between the LKB1 tumor suppressor, STRAD alpha/beta and MO25alpha/beta are upstream kinases in the AMP-activated protein kinase cascade. J. Biol. 2003, 2:28.
43. Heimberg M., Weinstein I., Kohout M. The effects of glucagon, dibutyryl cyclic adenosine 3',5'-monophosphate, and concentration of free fatty acid on hepatic lipid metabolism. J. Biol. Chem. 1969, 244:5131-5139.
44. Hems R., Ross B.D., Berry M.N., Krebs H.A. Gluconeogenesis in the perfused rat liver. Biochem. J. 1966, 101:284-292.
45. Herzig S., Long F., Jhala U.S., Hedrick S., Quinn R., Bauer A., Rudolph D., Schutz G., Yoon C., Puigserver P., Spiegelman B., Montminy M. CREB regulates hepatic gluconeogenesis through the coactivator PGC-1. Nature 2001, 413:179-183.
46. Hirsch I.B., Marker J.C., Smith L.J., Spina R.J., Parvin C.A., Holloszy J.O., Cryer P.E. Insulin and glucagon in prevention of hypoglycemia during exercise in humans. Am. J. Physiol. 1991, 260:E695-E704.
47. Holland R., Witters L.A., Hardie D.G. Glucagon inhibits fatty acid synthesis in isolated hepatocytes via phosphorylation of acetyl-CoA carboxylase by cyclic-AMP-dependent protein kinase. Eur. J. Biochem. 1984, 140:325-333.
48. Holland W.L., Miller R.A., Wang Z.V., Sun K., Barth B.M., Bui H.H., Davis K.E., Bikman B.T., Halberg N., Rutkowski J.M., Wade M.R., Tenorio V.M., Kuo M.S., Brozinick J.T., Zhang B.B., Birnbaum M.J., Summers S.A., Scherer P.E. Receptor-mediated activation of ceramidase activity initiates the pleotropic actions of adiponectin. Nat. Med. 2011, 17:55-63.
49. Hong Y.H., Varanasi U.S., Yang W., Leff T. AMP-activated protein kinase regulates HNF4alpha transcriptional activity by inhibiting dimer formation and decreasing protein stability. J. Biol. Chem. 2003, 278:495-501.
50. Horman S., Vertommen E., Heath R., Neumann D., Mouton V., Woods A., Schlattner U., Wallimann T., Carling D., Hue L., Rider M.H. Insulin-antagonizes ischemia-induced Thr172 phosphorylation of AMP-activated protein kinase alpha-subunits in heart via hierarchical phosphorylation of Ser485/491. J. Biol. Chem. 2006, 281:5335-5340.
51. Huynh F.K., Levi J., Denroche H.C., Gray S.L., Voshol P.J., Neumann U.H., Speck M., Chua S.C., Covey S.D., Kieffer T.J. Disruption of hepatic leptin signaling protects mice from age- and diet-related glucose intolerance. Diabetes 2010, 59:3032-3040.
52. Inoki K., Li Y., Zhu T., Wu J., Guan K.L. TSC2 is phosphorylated and inhibited by Akt and suppresses mTOR signaling. Nat. Cell. Biol. 2002, 4:648-657.
53. Inoki K., Zhu T., Guan K.L. TSC2 mediates cellular energy response to control cell growth and survival. Cell 2003, 115:577-590.
54. Iwabu M., Yamauchi T., Okada-Iwabu M., Sato K., Nakagawa T., Funata M., Yamaguchi M., Namiki S., Nakayama R., Tabata M., Ogata H., Kubota N., Takamoto I., Hayashi Y.K., Yamauchi N., Waki H., Fukayama M., Nishino I., Tokuyama K., Ueki K., Oike Y., Ishii S., Hirose K., Shimizu T., Touhara K., Kadowaki T. Adiponectin and AdipoR1 regulate PGC-1alpha and mitochondria by Ca(2+) and AMPK/SIRT1. Nature 2010, 464:1313-1319.
55. Jäger S., Handschin C., St-Pierre J., Spiegelman B.M. AMP-activated protein kinase (AMPK) action in skeletal muscle via direct phosphorylation of PGC-1alpha. Proc. Natl. Acad. Sci. USA 2007, 104:12017-12022.
56. Jaspan J.B., Ruddick J., Rayfield E. Transhepatic glucagon gradients in man: evidence for glucagon extraction by human liver. J. Clin. Endocrinol. Metab. 1984, 58:287-292.
57. Jungermann K., Kietzmann T. Zonation of parenchymal and nonparenchymal metabolism in liver. Ann. Rev. Nutr. 1996, 16:179-203.
58. Kelly D.P., Scarpulla R.C. Transcriptional regulatory circuits controlling mitochondrial biogenesis and function. Genes Dev. 2004, 18:357-368.
59. Kim Y.D., Park K.G., Lee Y.S., Park Y.Y., Kim D.K., Nedumaran B., Jang W.G., Cho W.J., Ha J., Lee I.K., Lee C.H., Choi H.S. Metformin inhibits hepatic gluconeogenesis through AMP-activated protein kinase-dependent regulation of the orphan nuclear receptor SHP. Diabetes 2008, 57:306-314.
60. Kimball S.R., Siegfried B.A., Jefferson L.S. Glucagon represses signaling through the mammalian target of rapamycin in rat liver by activating AMP-activated protein kinase. J. Biol. Chem. 2004, 279:54103-54109.
61. Kimmig R., Mauch T.J., Scholz R. Actions of glucagon on flux rates in perfused rat liver. 2. Relationship between inhibition of glycolysis and stimulation of respiration by glucagon. Eur. J. Biochem. 1983, 136:617-620.
62. Kola B., Hubina E., Tucci S.A., Kirkham T.C., Garcia E.A., Mitchell S.E., Williams L.M., Hawley S.A., Hardie D.G., Grossman A.B., Korbonits M. Cannabinoids and ghrelin have both central and peripheral metabolic and cardiac effects via AMP-activated protein kinase. J. Biol. Chem. 2005, 280:25196-25201.
63. Koo S.H., Flechner L., Qi L., Zhang X., Screaton R.A., Jeffries S., Hedrick S., Xu W., Boussouar F., Brindle P., Takemori H., Montminy M. The CREB coactivator TORC2 is a key regulator of fasting glucose metabolism. Nature 2005, 437:1109-1111.
64. Krishna M.G., Coker R.H., Lacy D.B., Zinker B.A., Halseth A.E., Wasserman D.H. Glucagon response to exercise is critical for accelerated hepatic glutamine metabolism and nitrogen disposal. Am. J. Physiol. Endocrinol. Metab. 2000, 279:E638-E645.
65. Laker R.C., Henry B.A., Wadley G.D., Clarke I.J., Canny B.J., McConell G.K. Central infusion of leptin does not increase AMPK signaling in skeletal muscle of sheep. Am. J. Physiol. Regul. Integ. Comput. Physiol. 2011, 300:R511-R518.
66. Lam C.K., Chari M., Rutter G.A., Lam T.K. Hypothalamic nutrient sensing activates a forebrain-hindbrain neuronal circuit to regulate glucose production in vivo. Diabetes 2011, 60:107-113.
67. Lavoie C., Ducros F., Bourque J., Langelier H., Chiasson J.L. Glucose metabolism during exercise in man: the role of insulin and glucagon in the regulation of hepatic glucose production and gluconeogenesis. Can. J. Physiol. Pharmacol. 1997, 75:26-35.
68. Leclerc I., Lenzner C., Gourdon L., Vaulont S., Kahn A., Viollet B. Hepatocyte nuclear factor-4alpha involved in type 1 maturity-onset diabetes of the young is a novel target of AMP-activated protein kinase. Diabetes 2001, 50:1515-1521.
69. Lee Y., Yu X., Gonzales F., Mangelsdorf D.J., Wang M.Y., Richardson C., Witters L.A., Unger R.H. PPAR alpha is necessary for the lipopenic action of hyperleptinemia on white adipose and liver tissue. Proc. Natl. Acad. Sci. USA 2002, 99:11848-11853.
70. Le Lay J., Tuteja G., White P., Dhir R., Ahima R., Kaestner K.H. CRTC2 (TORC2) contributes to the transcriptional response to fasting in the liver but is not required for the maintenance of glucose homeostasis. Cell. Metab. 2009, 10:55-62.
71. Leone T.C., Lehman J.J., Finck B.N., Schaeffer P.J., Wende A.R., Boudina S., Courtois M., Wozniak D.F., Sambandam N., Bernal-Mizrachi C., Chen Z., Holloszy J.O., Medeiros D.M., Schmidt R.E., Saffitz J.E., Abel E.D., Semenkovich C.F., Kelly D.P. PGC-1alpha deficiency causes multi-system energy metabolic derangements: muscle dysfunction, abnormal weight control and hepatic steatosis. PLoS. Biol. 2005, 3:e101.
72. Li S., Brown M.S., Goldstein J.L. Bifurcation of insulin signaling pathway in rat liver: mTORC1 required for stimulation of lipogenesis, but not inhibition of gluconeogenesis. Proc. Natl. Acad. Sci. USA 2010, 107:3441-3446.
73. Li X., Monks B., Qingyuan G., Birnbaum M.J. Akt/PKB regulates hepatic metabolism by directly inhibiting PGC-1α transcription coactivator. Nature 2007, 447:1012-1016.
74. Li Y., Xu S., Mihaylova M.M., Zheng B., Hou X., Jiang B., Park O., Luo Z., Lefai E., Shyy J.Y., Gao B., Wierzbicki M., Verbeuren T.J., Shaw R.J., Cohen R.A., Zang M. AMPK phosphorylates and inhibits SREBP activity to attenuate hepatic steatosis and atherosclerosis in diet-induced insulin-resistant mice. Cell Metab. 2011, 13:376-388.
75. Longuet C., Sinclair E.M., Maida A., Baggio L.L., Maziarz M., Charron M.J., Drucker D.J. The glucagon receptor is required for the adaptive metabolic response to fasting. Cell. Metab. 2008, 8:359-371.
76. Lustig Y., Ruas J.L., Estall J.L., Lo J.C., Devarakonda S., Laznik D., Choi J.H., Ono H., Olsen J.V., Spiegelman B.M. Separation of the gluconeogenic and mitochondrial functions of PGC-1{alpha} through S6 kinase. Genes Dev. 2011, 25:1232-1244.
77. Mabrouk G.M., Helmy I.M., Thampy K.G., Wakil S.J. Acute hormonal control of acetyl-CoA carboxylase. The roles of insulin, glucagon, and epinephrine. J. Biol. Chem. 1990, 265:6330-6338.
78. Mao X., Kikani C.K., Riojas R.A., Langlais P., Wang L., Ramos F.J., Fang Q., Christ-Roberts C.Y., Hong J.Y., Kim R.Y., Liu F., Dong L.Q. APPL1 binds to adiponectin receptors and mediates adiponectin signalling and function. Nat. Cell Biol. 2006, 8:516-523.
79. Mihaylova M.M., Vasquez D.S., Ravnskjaer K., Denechuad P.D., Yu R.T., Alvarez J.G., Downes M., Evans R.M., Montminy M., Shaw R.J. Class IIa histone deacetylases are hormone-activated regulators of FOXO and mammalian glucose homeostasis. Cell 2011, 145:607-621.
80. Miller R.A., Birnbaum M.J. An energetic tale of AMPK-independent effects of metformin. J. Clin. Invest. 2010, 120:2267-2270.
81. Miller R.A., Chu Q., Le Lay J., Scherer P.E., Ahima R.S., Kaestner K.H., Foretz M., Viollet B., Birnbaum M.J. Adiponectin suppresses gluconeogenic gene expression in mouse hepatocytes independent of LKB1-AMPK signaling. J. Clin. Invest. 2011, 121:2518-2528.
82. Minokoshi Y., Kim Y.B., Peroni O.D., Fryer L.G., Müller C., Carling D., Kahn B.B. Leptin stimulates fatty-acid oxidation by activating AMP-activated protein kinase. Nature 2002, 415:339-343.
83. Moon H.S., Chamberland J.P., Mantzoros C.S. Amylin and leptin activate overlapping signaling pathways in an additive manner in mouse GT1-7 hypothalamic, C2C12 muscle and AML12 liver cell lines. Diabetologia 2012, 55:215-225.
84. Munday M.R., Milic M.R., Takhar S., Holness M.J., Sugden M.C. The short-term regulation of hepatic acetyl-CoA carboxylase during starvation and re-feeding in the rat. Biochem. J. 1991, 280:733-737.
85. Muse E.D., Obici S., Bhanot S., Monia B.P., McKay R.A., Rajala M.W., Scherer P.E., Rossetti L. Role of resistin in diet-induced hepatic insulin resistance. J. Clin. Invest. 2004, 114:232-239.
86. Nakae J., Park B.C., Accili D. Insulin stimulates phosphorylation of the forkhead transcription factor FKHR on serine 253 through a Wortmannin-sensitive pathway. J. Biol. Chem. 1999, 274:15982-15985.
87. Nawrocki A.R., Rajala M.W., Tomas E., Pajvani U.B., Saha A.K., Trumbauer M.E., Pang Z., Chen A.S., Ruderman N.B., Chen H., Rossetti L., Scherer P.E. Mice lacking adiponectin show decreased hepatic insulin sensitivity and reduced responsiveness to peroxisome proliferator-activated receptor gamma agonists. J. Biol. Chem. 2006, 281:2654-2660.
88. Park H., Kaushik V.K., Constant S., Prentki M., Przybytkowski E., Ruderman N.B., Saha A.K. Coordinate regulation of malonyl-CoA decarboxylase, sn-glycerol-3-phosphate acyltransferase, and acetyl-CoA carboxylase by AMP-activated protein kinase in rat tissues in response to exercise. J. Biol. Chem. 2002, 277:32571-32577.
89. Potthoff M.J., Inagaki T., Satapati S., Ding X., He T., Goetz R., Mohammadi M., Finck B.N., Mangelsdorf D.J., Kliewer S.A., Burgess S.C. FGF21 induces PGC-1alpha and regulates carbohydrate and fatty acid metabolism during the adaptive starvation response. Proc. Natl. Acad. Sci. USA 2009, 106:10853-10858.
90. Puigserver P., Rhee J., Donovan J., Walkey C.J., Yoon J.C., Oriente F., Kitamura Y., Altomonte J., Dong H., Accili D., Spiegelman B.M. Insulin-regulated hepatic gluconeogenesis through FOXO1-PGC-1alpha interaction. Nature 2003, 423:550-555.
91. Qi Y., Nie Z., Lee Y.S., Singhal N.S., Scherer P.E., Lazar M.A., Ahima R.S. Loss of resistin improves glucose homeostasis in leptin deficiency. Diabetes 2006, 55:3083-3090.
92. Reiter A.K., Bolster D.R., Crozier S.J., Kimball S.R., Jefferson L.S. AMPK represses TOP mRNA translation but not global protein synthesis in liver. Biochem. Biophys. Res. Commun. 2008, 374:345-350.
93. Rhee J., Inoue Y., Yoon J.C., Puigserver P., Fan M., Gonzalez F.J., Spiegelman B.M. Regulation of hepatic fasting response by PPARgamma coactivator-1alpha (PGC-1): requirement for hepatocyte nuclear factor 4alpha in gluconeogenesis. Proc. Natl. Acad. Sci. USA 2003, 100:4012-4017.
94. Rivera N., Ramnanan C.J., An Z., Farmer T., Smith M., Farmer B., Irimia J.M., Snead W., Lautz M., Roach P.J., Cherrington A.D. Insulin-induced hypoglycemia increases hepatic sensitivity to glucagon in dogs. J. Clin. Invest. 2010, 120:4425-4435.
95. Ronnett G.V., Ramamurthy S., Kleman A.M., Landree L.E., Aja S. AMPK in the brain: its roles in energy balance and neuroprotection. J. Neurochem. 2009, 109:17-23.
96. Sapkota G.P., Kieloch A., Lizcano J.M., Lain S., Arthur J.S., Williams M.R., Morrice N., Deak M., Alessi D.R. Phosphorylation of the protein kinase mutated in Peutz-Jeghers cancer syndrome, LKB1/STK11, at Ser431 by p90(RSK) and cAMP-dependent protein kinase, but not its farnesylation at Cys(433), is essential for LKB1 to suppress cell growth. J. Biol. Chem. 2001, 276:19469-19482.
97. Scott J.W., van Denderen B.J., Jorgensen S.B., Honeyman J.E., Steinberg G.R., Oakhill J.S., Iseli T.J., Koay A., Gooley P.R., Stapleton D., Kemp B.E. Thienopyridone drugs are selective activators of AMP-activated protein kinase beta1-containing complexes. Chem. Biol. 2008, 15:1220-1230.
98. Screaton R.A., Conkright M.D., Katoh Y., Best J.L., Canettieri G., Jeffries S., Guzman E., Niessen S., Yates J.R., Takemori H., Okamoto M., Montminy M. The CREB coactivator TORC2 functions as a calcium- and cAMP-sensitive coincidence detector. Cell 2004, 119:61-74.
99. Shackelford D.B., Shaw R.J. The LKB1-AMPK pathway: metabolism and growth control in tumour suppression. Nat. Rev. Cancer. 2009, 9:563-575.
100. Shaw R.J., Kosmatka M., Bardeesy N., Hurley R.L., Witters L.A., DePinho R.A., Cantley L.C. The tumor suppressor LKB1 kinase directly activates AMP-activated protein kinase and regulates apoptosis in response to energy stress. Proc. Natl. Acad. Sci. USA 2004, 101:3329-3335.
101. Shaw R.J., Lamia K.A., Vasquez D., Koo S.H., Bardeesy N., Depinho R.A., Montminy M., Cantley L.C. The kinase LKB1 mediates glucose homeostasis in liver and therapeutic effects of metformin. Science. 2005, 310:1642-1646.
102. Sim A.T., Hardie D.G. The low activity of acetyl-CoA carboxylase in basal and glucagon stimulated hepatocytes is due to phosphorylation by AMP-activated protein kinase and not cyclic AMP-dependent protein kinase. FEBS Lett. 1988, 233:294-298.
103. Singhal N.S., Patel R.T., Qi Y., Lee Y.S., Ahima R.S. Loss of resistin ameliorates hyperlipidemia and hepatic steatosis in leptin-deficient mice. Am. J. Physiol. Endocrinol. Metab. 2008, 295:E331-E338.
104. Steinberg G.R., Watt M.J., Febbraio M.A. Cytokine regulation of AMPK signaling. Front. Biosci. 2009, 14:1902-1916.
105. Steppan C.M., Bailey S.T., Bhat S., Brown E.J., Banerjee R.R., Wright C.M., Patel H.R., Ahima R.S., Lazar M.A. The hormone resistin links obesity to diabetes. Nature 2001, 409:307-312.
106. Vega R.B., Huss J.M., Kelly D.P. The coactivator PGC-1 cooperates with peroxisome proliferator-activated receptor alpha in transcriptional control of nuclear genes encoding mitochondrial fatty acid oxidation enzymes. Mol. Cell. Biol. 2000, 20:1868-1876.
107. Wan M., Leavens K.F., Saleh D., Easton R.M., Guertin D.A., Peterson T.R., Kaestner K.H., Sabatini D.M., Birnbaum M.J. Postprandial hepatic lipid metabolism requires signaling through Akt2 independent of the transcription factors FoxA2, FoxO1, and SREBP-1c. Cell Metab. 2011, 14:516-527.
108. Wang B., Moya N., Niessen S., Hoover H., Mihaylova M.M., Shaw R.J., Yates J.R., Fischer W.H., Thomas J.B., Montminy M. A hormone-dependent module regulating energy balance. Cell 2011, 145:596-606.
109. Wasserman D.H. Four grams of glucose. Am. J. Physiol. Endocrinol. Metab. 2009, 296:E11-E21.
110. Wasserman D.H., Lacy D.B., Bracy D.P. Relationship between arterial and portal vein immunoreactive glucagon during exercise. J. Appl. Physiol. 1993, 75:724-729.
111. Wasserman D.H., Lickley H.L., Vranic M. Interactions between glucagon and other counterregulatory hormones during normoglycemic exercise in dogs. J. Clin. Invest. 1984, 74:1404-1413.
112. Wasserman D.H., Lickley H.L., Vranic M. Important role of glucagon during exercise in diabetic dogs. J. Appl. Physiol. 1985, 59:1272-1281.
113. Wasserman D.H., O'Doherty R.M., Zinker B.A. Role of the endocrine pancreas in control of fuel metabolism by the liver during exercise. Int. J. Obes. Relat. Metab. Disord. 1995, 19:S22-S30.
114. Wasserman D.H., Spalding J.A., Lacy D.B., Colburn C.A., Goldstein R.E., Cherrington A.D. Glucagon is a primary controller of hepatic glycogenolysis and gluconeogenesis during muscular work. Am. J. Physiol. 1989, 257:E108-E117.
115. Wasserman D.H., Williams P.E., Lacy D.B., Green D.R., Cherrington A.D. Importance of intrahepatic mechanisms to gluconeogenesis from alanine during exercise and recovery. Am. J. Physiol. 1988, 254:E518-E525.
116. Williamson J.R., Scholz R., Browning E.T. Control mechanisms of gluconeogenesis and ketogenesis. II. Interactions between fatty acid oxidation and the citric acid cycle in perfused rat liver. J. Biol. Chem. 1969, 244:4617-4627.
117. Witters L.A., Gao G., Kemp B.E., Quistorff B. Hepatic 5'-AMP-activated protein kinase: zonal distribution and relationship to acetyl-coA carboxylase activity in varying nutritional states. Arch. Biochem. Biophys. 1994, 308:413-419.
118. Witters L.A., Kemp B.E. Insulin activation of acetyl-CoA carboxylase accompanied by inhibition of the 5'-AMP-activated protein kinase. J. Biol. Chem. 1992, 267:2864-2867.
119. Woods A., Johnstone S.R., Dickerson K., Leiper F.C., Fryer L.G., Neumann D., Schlattner U., Wallimann T., Carlson M., Carling D. LKB1 is the upstream kinase in the AMP-activated protein kinase cascade. Curr. Biol. 2003, 13:2004-2008.
120. Woodside K.H., Ward W.F., Mortimore G.E. Effects of glucagon on general protein degradation and synthesis in perfused rat liver. J. Biol. Chem. 1974, 249:5458-5463.
121. Yamauchi T., Kamon J., Ito Y., Tsuchida A., Yokomizo T., Kita S., Sugiyama T., Miyagishi M., Hara K., Tsunoda M., Murakami K., Ohteki T., Uchida S., Takekawa S., Waki H., Tsuno N.H., Shibata Y., Terauchi Y., Froguel P., Tobe K., Koyasu S., Taira K., Kitamura T., Shimizu T., Nagai R., Kadowaki T. Cloning of adiponectin receptors that mediate antidiabetic metabolic effects. Nature 2003, 423:762-769.
122. Yamauchi T., Kamon J., Minokoshi Y., Ito Y., Waki H., Uchida S., Yamashita S., Noda M., Kita S., Ueki K., Eto K., Akanuma Y., Froguel P., Foufelle F., Ferre P., Carling D., Kimura S., Nagai R., Kahn B.B., Kadowaki T. Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase. Nat. Med. 2002, 8:1288-1295.
123. Yamauchi T., Nio Y., Maki T., Kobayashi M., Takazawa T., Iwabu M., Okada-Iwabu M., Kawamoto S., Kubota N., Kubota T., Ito Y., Kamon J., Tsuchida A., Kumagai K., Kozono H., Hada Y., Ogata H., Tokuyama K., Tsunoda M., Ide T., Murakami K., Awazawa M., Takamoto I., Froguel P., Hara K., Tobe K., Nagai R., Ueki K., Kadowaki T. Targeted disruption of AdipoR1 and AdipoR2 causes abrogation of adiponectin binding and metabolic actions. Nat. Med. 2007, 13:332-339.
124. Yang C.S., Lam C.K., Chari M., Cheung G.W., Kokorovic A., Gao S., Leclerc I., Rutter G.A., Lam T.K. Hypothalamic AMP-activated protein kinase regulates glucose production. Diabetes 2010, 59:2435-2443.
125. Yecies, J.L., Zhang, H.H., Menon, S., Liu., S., Yecies, D., Lipovsky, A.I., Gorgun, C., Kwiatkowski, D.J., Hotamisligil, G.S., Lee, C.H., Manning, B.D., 2011. Akt stimulates hepatic Srebp1c and lipogenesis through parallel mTORC1-dependent and independent pathways. Cell Metab. 14, 21-32.
126. Yoon J.C., Puigserver P., Chen G., Donovan J., Wu Z., Rhee J., Adelmant G., Stafford J., Kahn C.R., Granner D.K., Newgard C.B., Spiegelman B.M. Control of hepatic gluconeogenesis through the transcriptional coactivator PGC-1. Nature 2001, 413:131-138.
127. Yu X., McCorkle S., Wang M., Lee Y., Li J., Saha A.K., Unger R.H., Ruderman N.B. Leptinomimetic effects of AMP kinase activator AICAR in leptin-resistant rats: prevention of diabetes and ectopic lipid deposition. Diabetologia 2004, 47:2012-2021.
128. 2+/calmodulin-dependent protein kinase kinase-dependent pathways. J. Biol. Chem. 2009, 284:22426-22435.
129. Zong H., Ren J.M., Young L.H., Pypaert M., Mu J., Birnbaum M.J., Shulman G.I. AMP kinase is required for mitochondrial biogenesis in skeletal muscle in response to chronic energy deprivation. Proc. Natl. Acad. Sci. USA 2002, 99:15983-15987.